×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HCAT – health catalyst, inc - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HCAT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
08:47 am
hcat
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare [Yahoo! Finance]
Medium
Report
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare [Yahoo! Finance]
11/20
08:30 am
hcat
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare
Medium
Report
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare
11/19
08:00 am
hcat
Health Catalyst to Participate in Upcoming Investor Conferences
Medium
Report
Health Catalyst to Participate in Upcoming Investor Conferences
11/18
08:05 pm
hcat
Medical Terminology Software Market is Expected to Develop at a Stellar 19.4% CAGR through 2031 | SkyQuest Technology [Yahoo! Finance]
Low
Report
Medical Terminology Software Market is Expected to Develop at a Stellar 19.4% CAGR through 2031 | SkyQuest Technology [Yahoo! Finance]
11/14
08:14 am
hcat
Health Catalyst, Inc. (NASDAQ: HCAT) had its price target raised by analysts at Stephens from $7.00 to $9.00. They now have an "equal weight" rating on the stock.
Medium
Report
Health Catalyst, Inc. (NASDAQ: HCAT) had its price target raised by analysts at Stephens from $7.00 to $9.00. They now have an "equal weight" rating on the stock.
11/13
01:46 pm
hcat
Health Catalyst, Inc. (NASDAQ: HCAT) had its price target raised by analysts at Citigroup Inc. from $9.00 to $10.50. They now have a "buy" rating on the stock.
Low
Report
Health Catalyst, Inc. (NASDAQ: HCAT) had its price target raised by analysts at Citigroup Inc. from $9.00 to $10.50. They now have a "buy" rating on the stock.
11/13
08:30 am
hcat
Health Catalyst to Participate in Upcoming Investor Conference
High
Report
Health Catalyst to Participate in Upcoming Investor Conference
11/11
02:00 pm
hcat
Population Health Management Market to Grow by USD 22.55 Billion from 2024-2028, Driven by Rising Adoption of Healthcare IT, Report with AI Impact on Trends - Technavio [Yahoo! Finance]
Low
Report
Population Health Management Market to Grow by USD 22.55 Billion from 2024-2028, Driven by Rising Adoption of Healthcare IT, Report with AI Impact on Trends - Technavio [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
04:03 pm
hcat
health catalyst, inc - common stock
BEAT
Report
7.4%
health catalyst, inc - common stock
8/7/2024
04:13 pm
hcat
health catalyst, inc - common stock
MISS
Report
33.9%
health catalyst, inc - common stock
5/9/2024
04:03 pm
hcat
health catalyst, inc - common stock
BEAT
Report
-3.9%
health catalyst, inc - common stock
2/22/2024
04:03 pm
hcat
health catalyst, inc - common stock
BEAT
Report
-8.1%
health catalyst, inc - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
04:36 pm
hcat
Form 4 Health Catalyst, Inc. For: Nov 15 Filed by: Llewelyn Linda
Low
Report
Form 4 Health Catalyst, Inc. For: Nov 15 Filed by: Llewelyn Linda
11/15
04:34 pm
hcat
Form 144 Health Catalyst, Inc. Filed by: Llewelyn Linda
Medium
Report
Form 144 Health Catalyst, Inc. Filed by: Llewelyn Linda
11/14
07:52 pm
hcat
Form SC 13G/A Health Catalyst, Inc. Filed by: Point72 Asset Management, L.P.
High
Report
Form SC 13G/A Health Catalyst, Inc. Filed by: Point72 Asset Management, L.P.
11/14
04:45 pm
hcat
Form SC 13G Health Catalyst, Inc. Filed by: First Light Asset Management, LLC
Medium
Report
Form SC 13G Health Catalyst, Inc. Filed by: First Light Asset Management, LLC
11/12
03:55 pm
hcat
Form SC 13G/A Health Catalyst, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A Health Catalyst, Inc. Filed by: VANGUARD GROUP INC
11/8
10:30 am
hcat
Form SC 13G/A Health Catalyst, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Medium
Report
Form SC 13G/A Health Catalyst, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/7
06:05 pm
hcat
Form 4 Health Catalyst, Inc. For: Nov 05 Filed by: LeSueur Daniel
Medium
Report
Form 4 Health Catalyst, Inc. For: Nov 05 Filed by: LeSueur Daniel
11/7
06:01 am
hcat
Form 10-Q Health Catalyst, Inc. For: Sep 30
Medium
Report
Form 10-Q Health Catalyst, Inc. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
Health Catalyst Expands COVID-19 Response Support and Provides Infrastructure to Enable Readiness for Future Demands
14.1%
12/19 Health Catalyst (NASDAQ: HCAT) is now covered by analysts at Raymond James. They set a "strong-buy" rating on the stock. 11.7%
2/27 Q4/2019 12/31/2019 EPS -0.210 ZacksConsensus -0.280 ActVsEst 0.070 - Beat 9.7%
3/17 Health Catalyst Plans to Support Health System Clients' COVID-19 Response with Three Initial Solutions Focused on Patient Tracking, Public Health Surveillance and Staff Augmentation Support 8.1%
10/29 Health Catalyst (NASDAQ: HCAT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. 7.6%
4/3 Form 4 Health Catalyst, Inc. For: Apr 01 Filed by: Sanders Dale 7.6%
3/3 Form 4 Health Catalyst, Inc. For: Feb 28 Filed by: Dixon Michael Edward 6.8%
8/8 Health Catalyst to Announce Second Quarter 2019 Operating Results and Host Conference Call on Thursday, August 22, 2019 6.0%
11/12 Q3/2019 9/30/2019 EPS -0.270 ZacksConsensus -0.370 ActVsEst 0.100 - Beat 5.4%
11/19 Steward Health Care Chooses Health Catalyst for Data-Driven Patient Care Expansion 5.0%
12/19 Health Catalyst (NASDAQ: HCAT) is now covered by analysts at Raymond James. They set a "strong-buy" rating on the stock. 11.7%
2/27 Q4/2019 12/31/2019 EPS -0.210 ZacksConsensus -0.280 ActVsEst 0.070 - Beat 9.7%
3/17 Health Catalyst Plans to Support Health System Clients' COVID-19 Response with Three Initial Solutions Focused on Patient Tracking, Public Health Surveillance and Staff Augmentation Support 8.1%
10/29 Health Catalyst (NASDAQ: HCAT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. 7.6%
4/3 Form 4 Health Catalyst, Inc. For: Apr 01 Filed by: Sanders Dale 7.6%
3/3 Form 4 Health Catalyst, Inc. For: Feb 28 Filed by: Dixon Michael Edward 6.8%
8/8 Health Catalyst to Announce Second Quarter 2019 Operating Results and Host Conference Call on Thursday, August 22, 2019 6.0%
11/12 Q3/2019 9/30/2019 EPS -0.270 ZacksConsensus -0.370 ActVsEst 0.100 - Beat 5.4%
11/19 Steward Health Care Chooses Health Catalyst for Data-Driven Patient Care Expansion 5.0%
TOP News Decliners
4/8
Health Catalyst, Inc. Announces Proposed Offering of $175 Million Convertible Senior Notes
-10.4%
8/23 Form 10-Q Health Catalyst, Inc. For: Jun 30 -10.2%
4/29 Form 4 Health Catalyst, Inc. For: Apr 28 Filed by: Sanders Dale -4.9%
2/20 Form 4 Health Catalyst, Inc. For: Feb 14 Filed by: Bullock D Fraser -4.3%
10/22 Health Catalyst (NASDAQ: HCAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $32.00 price target on the stock. -3.1%
12/9 Health Catalyst (NASDAQ: HCAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $46.00 price target on the stock. -3.0%
4/15 Form 4 Health Catalyst, Inc. For: Apr 13 Filed by: Dixon Michael Edward -2.9%
2/11 Form 4 Health Catalyst, Inc. For: Feb 07 Filed by: Larson-Green Julie -2.7%
4/14 Health Catalyst and Carle Health Partner to Improve Patient Care with Data and Analytics Solutions -2.6%
7/31 Health Catalyst-Using Analytics As A Catalyst For Better Healthcare Results [Seeking Alpha] -2.5%
8/23 Form 10-Q Health Catalyst, Inc. For: Jun 30 -10.2%
4/29 Form 4 Health Catalyst, Inc. For: Apr 28 Filed by: Sanders Dale -4.9%
2/20 Form 4 Health Catalyst, Inc. For: Feb 14 Filed by: Bullock D Fraser -4.3%
10/22 Health Catalyst (NASDAQ: HCAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $32.00 price target on the stock. -3.1%
12/9 Health Catalyst (NASDAQ: HCAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $46.00 price target on the stock. -3.0%
4/15 Form 4 Health Catalyst, Inc. For: Apr 13 Filed by: Dixon Michael Edward -2.9%
2/11 Form 4 Health Catalyst, Inc. For: Feb 07 Filed by: Larson-Green Julie -2.7%
4/14 Health Catalyst and Carle Health Partner to Improve Patient Care with Data and Analytics Solutions -2.6%
7/31 Health Catalyst-Using Analytics As A Catalyst For Better Healthcare Results [Seeking Alpha] -2.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: